1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Delayed Xetra  -  05/24 11:35:22 am EDT
323.00 EUR   +0.16%
05/24SARTORIUS VORZUEGE : Buy rating from Berenberg
MD
05/19Sartorius Announces Further Growing its Global Production Capacity with Expansion of its Manufacturing Site in Tunisia
CI
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs

11/26/2021 | 12:34pm EDT

By Cecilia Butini

Sartorius AG said Friday that it would invest a total of 100 million euros ($112.1 million) between 2021 and 2025 in France, creating up to 400 permanent-employment positions.

The German biopharmaceutical company said it plans to expand and upgrade facilities in Aubagne, Cergy and Lourdes.

"This investment will enable the company to further boost performance and become even more innovative as well as to meet the growing demand of the market," it said.

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

11-26-21 1234ET

Stocks mentioned in the article
ChangeLast1st jan.
SARTORIUS AG 0.16% 323 Delayed Quote.-35.27%
SARTORIUS STEDIM BIOTECH -0.71% 309.1 Real-time Quote.-35.92%
All news about SARTORIUS AG
05/24SARTORIUS VORZUEGE : Buy rating from Berenberg
MD
05/19Sartorius Announces Further Growing its Global Production Capacity with Expansion of it..
CI
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
04/26SARTORIUS VORZUEGE : Warburg Research reaffirms its Buy rating
MD
04/22SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
04/22SARTORIUS VORZUEGE : Deutsche Bank maintains a Buy rating
MD
04/22SARTORIUS VORZUEGE : Berenberg maintains a Buy rating
MD
04/21TRANSCRIPT : Sartorius Aktiengesellschaft, Q1 2022 Earnings Call, Apr 21, 2022
CI
04/21SARTORIUS : Conference Call Q1|2022 Presentation
PU
04/21SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg
MD
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2022 4 139 M 4 441 M 4 441 M
Net income 2022 574 M 616 M 616 M
Net Debt 2022 1 457 M 1 564 M 1 564 M
P/E ratio 2022 36,2x
Yield 2022 0,37%
Capitalization 22 618 M 24 268 M 24 268 M
EV / Sales 2022 5,82x
EV / Sales 2023 5,24x
Nbr of Employees 15 051
Free-Float 33,3%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 323,00 €
Average target price 443,55 €
Spread / Average Target 37,3%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-35.27%24 330
REVENIO GROUP OYJ-16.90%1 310
BIOTAGE AB (PUBL)-26.60%1 292
VAREX IMAGING CORPORATION-29.60%884
CELLAVISION AB (PUBL)4.55%826
908 DEVICES INC.-46.50%450